| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-13 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
5e-05 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0003 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0004 |